Burkitt Lymphoma
📧 Sign up to get email alerts when something new happens for Burkitt Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a terminated phase 1/2 trial evaluating fenretinide with rituximab for B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy plus rituximab for adults with Burkitt lymphoma or B-cell acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial from the Children's Oncology Group assesses Rituximab, Rasburicase, and combination chemotherapy in children with newly diagno…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update evaluating the combination of iodine-131 tositumomab with fludarabine phosphate in older patients undergoing autologous…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Imexon for Relapsed Follicular and Aggressive Lymphomas [Phase 2]
Phase 2 clinical trial results for imexon in relapsed follicular lymphoma and various aggressive B-cell lymphomas have been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 study evaluating vorinostat with or without isotretinoin in pediatric patients with recurrent or refractory solid tumors, lymphoma, …
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial of pegylated liposomal doxorubicin (Doxil) with rituximab for relapsed AIDS-related non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of ixabepilone in relapsed or refractory aggressive non-Hodgkin lymphoma across multiple su…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: FAU in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating FAU in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy [EARLY_Phase 1]
A Phase 1 study evaluating the safety and tolerability of combining sirolimus with Hyper-CVAD chemotherapy in adults with lymphoid malignanc…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia [Phase 2]
Phase 2 trial evaluating a combination chemotherapy regimen for Burkitt's lymphoma or Burkitt's leukemia; the study status is completed.
-
CLINICAL_TRIALS research · 2013-10-22Clinical Trial Update: Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
An observational study was completed evaluating cytofluorimetric analysis of cerebrospinal fluid in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating combination chemotherapy with rituximab in children with recurrent or refractory B-cell non-Hodgkin lymphoma or acu…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial evaluating Triapine (3-AP) in combination with gemcitabine in patients with advanced solid tumors or lymphoma has completed. I…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial evaluating rituximab in combination with interleukin-2 in various hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating decitabine with or without valproic acid in relapsed or refractory non-Hodgkin lymphoma, including Burkitt lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma [Phase 2]
A Phase 2 trial evaluating intensive chemotherapy with rituximab for Burkitt lymphoma and non-Hodgkin lymphoma was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating PXD101 in combination with 17-N-allylamino-17-demethoxygeldanamycin for metastatic or unresectable solid tumors o…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
A Phase 1 study evaluating belinostat (PXD101) in combination with bortezomib in adults with advanced solid tumors or lymphomas has complete…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the combination of clofarabine and cyclophosphamide in patients with acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in combination with chemotherapy for newly diagnosed HIV-associated Burkitt lymphoma has completed, with …
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating interleukin-2 versus observation after standard therapy in adults with recurrent non-Hodgkin lymphoma has complet…